Table 1.
Nutritional Treatment | Type of the Study | Authors | Year | Organ/System/Metabolic Target |
Duration of Intervention | Impact of Intervention |
---|---|---|---|---|---|---|
CRD | Animal study | Zanetti et al. [64] | 2010 |
|
3 weeks | ↓ Oxidative stress ↓ iNOS ↓ Total nitrite ↓ Calcium-independent NOS activity ↑ SOD activity |
CRD | Animal study | Rippe et al. [65] | 2010 |
|
8 weeks | ↓ Oxidative stress ↓ Blood glucose ↓ TG ↑ NO bioavailability ↑ Arterial expression of SIRT1 |
CRD | Animal study | Donato et al. [66] | 2013 |
|
30–31 months | ↓ NADPH oxidase activity ↓ Oxidative stress ↓ TG ↓ BW ↑ SOD activity ↑ Catalase |
CRD | Animal study | Kobara et al. [67] | 2015 |
|
4 weeks | ↓ ROS ↓ Cardiac hypertrophy and fibrosis |
CRD | Animal study | Waldman et al. [68] | 2018 |
|
4 weeks | ↓ Oxidative stress ↓ Inflammation ↑ SIRT1 |
CRD | Animal study | An et al. [69] | 2020 |
|
12 weeks | ↓ Cardiac hypertrophy and fibrosis ↓ Cardiac inflammation ⇅ Cellular regulation of iron homeostasis |
CRD | Human study | Wadden et al. [70] | 1998 |
|
40 weeks | ↓ BW ↓ FM ↓ Serum leptin |
CRD | Human study | Nakano et al. [71] | 2001 |
|
2 weeks | ↓ BMI ↓ BW ↓ TG ↓ HOMA-index ↓ SBP ↓ DBP |
CRD | Human study | Facchini et al. [72] | 2003 |
|
3 weeks | ↓ BMI ↓ Heart rate ↑ Parasympathetic activity |
CRD | Human study | Das et al. [73] | 2007 |
|
12 months | ↓ FM ↓ BW ↓ TG ↓ insulin ↓ LDL-c ↓ TC ↑ HDL-c |
CRD | Human study | Lecoultre et al. [74] | 2011 |
|
6 months | ↓ BW ↓ Mean 24 h circulating leptin ↓ Urinary norepinephrine |
CRD | Human study | Stewart et al. [75] | 2013 |
|
24 months | ↓ LDL-c ↓ TC/HDL-c↓ TG ↓ DBP ↓ BW ↓ BMI ↓ FM ↓ MSS ↑ IS |
CRD | Human study | Ruggenenti et al. [76] | 2017 |
|
6 months | ↓ WC ↓ BW ↓ BMI ↓ BG ↓ HbA1c |
CRD | Human study | Most et al. [77] | 2018 |
|
24 months | ↓ VAT ↓ SAAT ↓ SBP ↓ DBP ↓ TC ↓ LDL-c ↓ IR |
CRD | Human study | Kraus et al. [78] | 2019 |
|
24 months | ↓ LDL-c ↓ TC/HDL-c ↓ SBP ↓ DBP ↓ MSS ↑ IS |
DASH DIET | Human study | Harsha et al. [79] | 1999 |
|
8 weeks | ↓ SBP ↓ DBP |
IF | Human study | Arnason et al. [80] | 2017 |
|
6 weeks | ↓ BW ↓ BMI |
IF | Human study | Erdem et al. [81] | 2018 |
|
- | ↓ SBP ↓ Heart rate ↓ USE |
IF | Human study | Furmli et al. [82] | 2018 |
|
12 weeks | ↓ HbA1c ↓ BW ↓ WC |
IF | Human study | Wilhelmi de Toledo et al. [83] | 2019 |
|
24 months | ↓ SBP ↓ DBP ↓ BW ↓ Abdominal circumference ↓ Blood glucose ↓ TG ↓ LDL-c ↓ HDL-c ↓ TC ↑ Physical and emotional well-being |
CRD vs IF | Animal study | Magger et al. [84] | 2006 |
|
16 weeks | ↓ BW ↓ Heart rate ↓ SBP ↓ DBP ↓ Blood glucose |
Abbreviations: ANS, autonomic nervous system; BG, blood glucose; BMI, body mass index; BW, body weight; CRD, caloric restriction diet; DBP, diastolic blood pressure; FM, fat mass; HbA1c, glycated hemoglobin; HDL-c, high-density lipoprotein cholesterol; IF, intermittent fasting; iNOS, inducible nitric oxide synthase; IR, insulin resistance; IS, insulin sensitivity; LDL-c, low density lipoprotein cholesterol; MSS, metabolic syndrome score; NADPH, nicotinamide adenine dinucleotide phosphate; NO, nitric oxide; ROS, reactive oxygen species; SAAT, subcutaneus abdominal adipose tissue; SBP, systolic blood pressure; SIRT1, sirtuin 1; SOD, superoxide dismutase; TC, total cholesterol; TG, triglycerides; USE, urinary sodium excretion; VAT, visceral adipose tissue; WC, waist circumference, ↑ increase, ↓ decrease.